229 related articles for article (PubMed ID: 8957691)
1. Anti-proliferative effect of the kinase inhibitor K252a on human prostatic carcinoma cell lines.
Delsite R; Djakiew D
J Androl; 1996; 17(5):481-90. PubMed ID: 8957691
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of chemomigration of a human prostatic carcinoma cell (TSU-pr1) line by inhibition of epidermal growth factor receptor function.
Zolfaghari A; Djakiew D
Prostate; 1996 Apr; 28(4):232-8. PubMed ID: 8602399
[TBL] [Abstract][Full Text] [Related]
3. Regulation of growth by a nerve growth factor-like protein which modulates paracrine interactions between a neoplastic epithelial cell line and stromal cells of the human prostate.
Djakiew D; Delsite R; Pflug B; Wrathall J; Lynch JH; Onoda M
Cancer Res; 1991 Jun; 51(12):3304-10. PubMed ID: 1710170
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle-independent death of prostate adenocarcinoma is induced by the trk tyrosine kinase inhibitor CEP-751 (KT6587).
Dionne CA; Camoratto AM; Jani JP; Emerson E; Neff N; Vaught JL; Murakata C; Djakiew D; Lamb J; Bova S; George D; Isaacs JT
Clin Cancer Res; 1998 Aug; 4(8):1887-98. PubMed ID: 9717816
[TBL] [Abstract][Full Text] [Related]
5. Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high-affinity nerve growth factor binding sites involving tyrosine kinase signaling.
Oelmann E; Sreter L; Schuller I; Serve H; Koenigsmann M; Wiedenmann B; Oberberg D; Reufi B; Thiel E; Berdel WE
Cancer Res; 1995 May; 55(10):2212-9. PubMed ID: 7538048
[TBL] [Abstract][Full Text] [Related]
6. Detection of NGF-receptors TrkA and p75NTR in human tumor cell lines and effect of NGF on the growth characteristic of the UT-7/EPO cell line.
Westphal G; van den Berg-Stein S; Braun K; Knoch TA; Dümmerling M; Langowski J; Debus J; Friedrich E
J Exp Clin Cancer Res; 2002 Jun; 21(2):255-67. PubMed ID: 12148587
[TBL] [Abstract][Full Text] [Related]
7. K252a is a selective inhibitor of the tyrosine protein kinase activity of the trk family of oncogenes and neurotrophin receptors.
Tapley P; Lamballe F; Barbacid M
Oncogene; 1992 Feb; 7(2):371-81. PubMed ID: 1312698
[TBL] [Abstract][Full Text] [Related]
8. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
9. Trk receptor inhibition induces apoptosis of proliferating but not quiescent human osteoblasts.
Pinski J; Weeraratna A; Uzgare AR; Arnold JT; Denmeade SR; Isaacs JT
Cancer Res; 2002 Feb; 62(4):986-9. PubMed ID: 11861369
[TBL] [Abstract][Full Text] [Related]
10. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).
George DJ; Dionne CA; Jani J; Angeles T; Murakata C; Lamb J; Isaacs JT
Cancer Res; 1999 May; 59(10):2395-401. PubMed ID: 10344749
[TBL] [Abstract][Full Text] [Related]
11. K252a inhibits proliferation of glioma cells by blocking platelet-derived growth factor signal transduction.
Chin LS; Murray SF; Zitnay KM; Rami B
Clin Cancer Res; 1997 May; 3(5):771-6. PubMed ID: 9815748
[TBL] [Abstract][Full Text] [Related]
12. K252a is highly effective in suppressing the growth of human endometrial cancer cells, but has little effect on normal human endometrial epithelial cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Oncol Rep; 2008 Mar; 19(3):749-53. PubMed ID: 18288411
[TBL] [Abstract][Full Text] [Related]
13. Expression of a Trk high affinity nerve growth factor receptor in the human prostate.
Pflug BR; Dionne C; Kaplan DR; Lynch J; Djakiew D
Endocrinology; 1995 Jan; 136(1):262-8. PubMed ID: 7828539
[TBL] [Abstract][Full Text] [Related]
14. Pan-trk inhibition decreases metastasis and enhances host survival in experimental models as a result of its selective induction of apoptosis of prostate cancer cells.
Weeraratna AT; Dalrymple SL; Lamb JC; Denmeade SR; Miknyoczki S; Dionne CA; Isaacs JT
Clin Cancer Res; 2001 Aug; 7(8):2237-45. PubMed ID: 11489797
[TBL] [Abstract][Full Text] [Related]
15. Induction of cell cycle arrest and apoptosis in human prostate carcinoma cells by a recombinant adenovirus expressing p27(Kip1).
Katner AL; Hoang QB; Gootam P; Jaruga E; Ma Q; Gnarra J; Rayford W
Prostate; 2002 Sep; 53(1):77-87. PubMed ID: 12210483
[TBL] [Abstract][Full Text] [Related]
16. Nitroxide tempo, a small molecule, induces apoptosis in prostate carcinoma cells and suppresses tumor growth in athymic mice.
Suy S; Mitchell JB; Samuni A; Mueller S; Kasid U
Cancer; 2005 Mar; 103(6):1302-13. PubMed ID: 15685617
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase C mediated anti-proliferative glucocorticoid-sphinganine synergism in cultured Pollard III prostate tumor cells.
Sosnowski J; Stetter-Neel C; Cole D; Durham JP; Mawhinney MG
J Urol; 1997 Jul; 158(1):269-74. PubMed ID: 9186373
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms controlling cell cycle arrest and induction of apoptosis after 12-lipoxygenase inhibition in prostate cancer cells.
Pidgeon GP; Kandouz M; Meram A; Honn KV
Cancer Res; 2002 May; 62(9):2721-7. PubMed ID: 11980674
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro.
Festuccia C; Muzi P; Gravina GL; Millimaggi D; Speca S; Dolo V; Ricevuto E; Vicentini C; Bologna M
Int J Oncol; 2007 Jan; 30(1):193-200. PubMed ID: 17143529
[TBL] [Abstract][Full Text] [Related]
20. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A
Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]